Closely linked polymorphic markers for determining the autosomal dominant allele (Cy) in rat polycystic kidney disease

被引:10
|
作者
Nagao, S [1 ]
Ushijima, T
Kasahara, M
Yamaguchi, T
Kusaka, M
Matsuda, J
Nagao, M
Takahashi, H
机构
[1] Fujita Hlth Univ, Inst Comprehens Med Sci, Lab Anim Ctr, Aichi 4701192, Japan
[2] Natl Canc Ctr, Res Inst, Cacinogenesis Div, Chuo Ku, Tokyo 1040045, Japan
[3] Fujita Hlth Univ, Sch Med, Dept Pathol, Aichi 4701192, Japan
关键词
polycystic kidney; polymorphism; rat; Cy; gene;
D O I
10.1023/A:1018742807031
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Han:SPRD strain is an SD-background strain known to be a model of polycystic kidney disease (PKD) expressed through an autosomal dominant gene (Cy). However, different genotypes of this strain cannot be identified in the neonatal period. First, to establish an accurate method of determining the genotypes (Cy/Cy, Cy/+, +/+) which cause different disease progressions, we used polymorphic markers on rat chromosome 5. PCR products of tissue DNA templated with D5Rat9 showed distinct patterns on electrophoresis indicating three genotypes. Second, to determine whether the same locus plays a major role in expressing PKD, we performed linkage analyses ina a [BN x (BN x Han:SPRD)F-1] backcross. Cy/Cy and Cy/+ also caused PKD in a BN background. In this backcross, we discovered that D5Rat11 is located closer to the Cy locus than DSMgh10, which is regarded as one of the closest loci. We conclude that D5Rat9 and D5Rat11 are useful markers for deter-mining the presence of the Cy allele, which is regarded as the gene responsible for PKD.
引用
收藏
页码:227 / 235
页数:9
相关论文
共 50 条
  • [41] Genotype-phenotype of autosomal dominant polycystic kidney disease in Malta
    Ciantar, Natalie
    Zahra, Graziella
    Delicata, Julian
    Sammut, Fiona
    Calleja-Agius, Jean
    Farrugia, Emanuel
    Said, Edith
    EUROPEAN JOURNAL OF MEDICAL GENETICS, 2024, 69
  • [42] Retroperitoneoscopic nephrectomy for autosomal dominant polycystic kidney disease: Initial experience
    Wyler, Stephen F.
    Bachmann, Alexander
    Ruszat, Robin
    Forster, Thomas
    Hudolin, Tvrtko
    Gasser, Thomas C.
    Sulser, Tullio
    UROLOGIA INTERNATIONALIS, 2007, 79 (02) : 137 - 141
  • [43] Autosomal Dominant Polycystic Kidney Disease Inflammation Biomarkers in the Tolvaptan Era
    Lapao, Tania
    Barata, Rui
    Jorge, Cristina
    Flores, Carlos
    Calado, Joaquim
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (03)
  • [44] What Is the Role of Somatic Mutation in Autosomal Dominant Polycystic Kidney Disease?
    Harris, Peter C.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 21 (07): : 1073 - 1076
  • [45] Advances in autosomal dominant polycystic kidney disease-2014 and beyond
    Braun, William E.
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2014, 81 (09) : 544 - 555
  • [46] Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease
    Harris, Peter C.
    Torres, Vicente E.
    JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (06) : 2315 - 2324
  • [47] Hyperuricemia and deterioration of renal function in autosomal dominant polycystic kidney disease
    Miyeun Han
    Hayne Cho Park
    Hyunsuk Kim
    Hyung Ah Jo
    Hyuk Huh
    Joon Young Jang
    Ah-Young Kang
    Seung Hyup Kim
    Hae Il Cheong
    Duk-Hee Kang
    Jaeseok Yang
    Kook-Hwan Oh
    Young-Hwan Hwang
    Curie Ahn
    BMC Nephrology, 15
  • [48] THE ROLE OF MTOR INHIBITION IN THE CONTROL OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
    Perico, N.
    Remuzzi, G.
    DRUGS OF THE FUTURE, 2010, 35 (11) : 929 - 938
  • [49] Endothelial nitric oxide synthase affects the progression of autosomal dominant polycystic kidney disease
    Reiterová, J
    Merta, M
    Tesar, V
    Stekrová, J
    KIDNEY & BLOOD PRESSURE RESEARCH, 2002, 25 (02) : 87 - 90
  • [50] Autosomal dominant polycystic kidney disease caused by somatic and germline mosaicism
    Tan, A. Y.
    Blumenfeld, J.
    Michaeel, A.
    Donahue, S.
    Bobb, W.
    Parker, T.
    Levine, D.
    Rennert, H.
    CLINICAL GENETICS, 2015, 87 (04) : 373 - 377